Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

3 Standout Stocks to Buy as Worse-Than-Expected CPI Numbers Revive Inflation Fears

Published 09/13/2023, 04:30 AM
Updated 09/02/2020, 02:05 AM
  • The August CPI report showed headline annual inflation rising 3.7% compared to the 3.2% reading seen in July and a 3.0% increase in June.
  • As inflation makes a comeback, I used the InvestingPro stock screener to identify some of the best stocks that tend to deliver strong returns during periods of elevated CPI.
  • Looking for more actionable trade ideas to navigate the current market volatility? Members of InvestingPro get exclusive ideas and guidance to navigate any climate. Learn More »
  • The U.S. government has just released the August inflation report, with numbers revealing that CPI has continued to rise at a pace far more quickly than the 2% rate the Fed considers healthy for the economy.

    The consumer price index rose by 0.6% on the month, after edging up 0.2% in July. The headline annual inflation rate rose above market expectations, at 3.7%, marking a significant acceleration from the 3.2% annual pace in the previous month.

    To help you successfully navigate through the uncertain macro backdrop, I used the InvestingPro screener to identify some of the best stocks that tend to deliver strong returns during times of high inflation, like now.

    My focus was on diversified companies that are defensive in nature and demonstrate solid profitability, a healthy balance sheet, strong growth prospects, and resilient dividend payouts thanks to their market-leading position.

    To kick off my process, I first searched for stocks that hail from defensive sectors of the market, such as consumer staples, energy, utilities, and healthcare, as their products and services are essential to people’s everyday lives. InvestingPro Stock ScreenerSource: InvestingPro

    I then filtered for stocks with a dividend yield above 2.5%.

    Finally, I scanned for names that have an InvestingPro Profit Health Label of either ‘Excellent’ or ‘Great.’ The grade is based on the strength of the company’s projected earnings growth and cash flow trends.

    My watchlist consists of companies with a market cap of over $10 billion, an average daily trading volume of at least one million shares, and a stock price of $10 or higher.

    Only 26 stocks on U.S. exchanges met the criteria above. Of those, here are three standout companies to own as inflation fears return.

    For the full list of stocks that made my watchlist, start your 7-day free trial with InvestingPro. If you're already an InvestingPro subscriber, you can view my selections here.

    1. Johnson & Johnson

    Johnson & Johnson (NYSE:JNJ) is one of the most valuable drug and medical device makers in the world, best known for its various blockbuster immunology, oncology, and cardiovascular drugs.

    The healthcare giant recently spun off its consumer health business Kenvue (NYSE:KVUE), following in the footsteps of several other drugmakers that have slimmed down to focus on their pharmaceutical units.

    J&J has a stellar track record of weathering economic storms and tends to exhibit resilience during periods of inflation as demand for medical products and services remains steady.

    The New Brunswick, New Jersey-based company’s reputation for innovation and a robust pipeline of promising drugs positions it for growth, even as inflation returns.

    Moreover, J&J’s relatively high annualized dividend and attractive yield - currently at $4.76 and 2.91%, respectively - further enhances the appeal of the diversified healthcare juggernaut.

    In fact, it is one of only two U.S.-based companies that has a prime credit rating of ‘AAA’, higher than that of the U.S. government and has raised its dividend every year for 52 consecutive years.Johnson and Johnson Company ProfileSource: InvestingPro

    According to a number of valuation models, including P/E multiples, the average ‘Fair Value’ price target for JNJ stock on InvestingPro stands at $182.95, a potential 12% upside from the current market value.

    Taking that into account, owning Johnson & Johnson shares during times of rising inflation presents several advantages thanks to the company’s strong balance sheet and long history of not only paying dividends but also increasing them over time.

    2. PepsiCo

    PepsiCo (NASDAQ:PEP) meets my strict criteria of profitable blue-chip companies that do well in times of rising inflationary pressures and economic uncertainty.

    The well-diversified consumer products company operates in 200 countries and sells a wide range of popular items that people consume regardless of economic conditions.

    Additionally, PepsiCo's pricing power allows it to adjust to rising input costs, mitigating the impact of inflation on its profit margins.

    The global beverage and snack giant currently has 23 brands in its portfolio that produce over $1 billion in annual sales, including notable soft drinks such as Pepsi, Gatorade, and Tropicana, as well as recognizable snack labels like Lay’s, Fritos, Doritos, and Cheetos.

    The New York-based company is also a reliable dividend payer with a history of consistent dividend growth. In fact, PepsiCo’s dividend payout has experienced 50 consecutive years of growth, earning it the status of ‘Dividend King.’PepsiCo InvestingProSource: InvestingPro

    As per InvestingPro, investors have the chance to buy PepsiCo’s stock at a modest discount. The average ‘Fair Value’ price estimate for PEP stands at $185.59/share, implying a potential upside of 4.1%.

    All things considered, PepsiCo’s strong global presence, diverse product portfolio, stable dividend history, and commitment to innovation make it a standout choice for investors looking to navigate the ongoing challenges of elevated inflationary pressures.

    3. NextEra Energy

    NextEra Energy (NYSE:NEE), which stands out in the utilities sector as a renewable energy leader, has the potential to deliver strong returns as inflation concerns resurface.

    Stocks of defensive companies whose products and services are essential to people’s everyday lives, such as utility providers, tend to outperform in environments of accelerating inflation.

    The Juno Beach, Florida-based utility giant, which is the world’s largest generator of wind and solar electricity, looks primed to continue to benefit from the ongoing shift to clean energy.

    NextEra’s long-term contracts and regulated utilities business provide steady cash flows, making it a reliable choice for investors seeking insulation from inflation-related uncertainties.

    In addition, the renewable energy company’s consistent dividend payouts and focus on shareholder value make it a solid choice for income-oriented investors.

    NextEra Energy has maintained a streak of 27 consecutive years in which it has raised its annual dividend.NextEra Energy InvestingProSource: InvestingPro

    Indeed, shares could see an upside of 10.3% from Tuesday’s closing price according to the quantitative models in InvestingPro, bringing NEE stock closer to its ‘Fair Value’ price of around $75.

    All in all, NextEra Energy’s strong financial position, diverse renewable energy portfolio, steady cash flows, and commitment to dividend growth make its shares a compelling option as inflation fears return.

    Be sure to check out InvestingPro to stay in sync with the market trend and what it means for your trading decisions.

    ***

    Find All the Info you Need on InvestingPro!

    Disclosure: At the time of writing, I am long on the Dow Jones Industrial Average via the SPDR Dow ETF. I also have a long position on the Energy Select Sector SPDR ETF (NYSE:XLE) and the Health Care Select Sector SPDR ETF (NYSE:XLV). Additionally, I am short on the S&P 500, Nasdaq 100, and Russell 2000 via the ProShares Short S&P 500 ETF, ProShares Short QQQ ETF, and ProShares Short Russell 2000 ETF. I regularly rebalance my portfolio of individual stocks and ETFs based on ongoing risk assessment of both the macroeconomic environment and companies' financials. The views discussed in this article are solely the opinion of the author and should not be taken as investment advice.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

This was subtrifuge. Do you really believe what you wrote???
NEE went from 70 to sub50
So far this has been generally bad advise as I see it.
You were wrong again!
Would you explain your suggestion to buy Oracle…only to see it drop the following day?
0.01% worse than expected yet the sticky part of inflation that everyone has been panicking about fell swiftly
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.